Local Storage seems to be disabled in your browser.
For the best experience on our site, be sure to turn on Local Storage in your browser.
Optimmune-canis 3,5 g
Ciclosporine A 0,2 % (2,0 mg/g) to treat chronic keratoconjunctivitis sicca and chronic superficial keratitis in dogs
Optimmune is a white petrolatum based ointment for ophthalmic use, containing 0.2% w/w cyclosporin Ph. Eur.
Cyclosporin is an immunosuppressant with lacrimomimetic and anti-inflammatory properties.In the dog, Optimmune is indicated for the treatment of chronic recurrent conjunctivitis resulting from auto-immune disease of the eye. Optimmune is indicated for the therapeutic treatment of keratoconjunctivitis sicca (KCS, `dry eye') and chronic superficial keratitis (`pannus'). Optimmune may be used to augment topical corticosteroids or as a substitute for corticosteroids when these are contraindicated by corneal ulceration.
Dosage and administration
For topical administration to the conjunctival sac. Apply a small amount of ointment (approximately 1/4 inch or 1/2 cm) into the affected eye(s) every 12 hours.
Any excessive discharge in the eye should be removed prior to application of the ointment by gently cleansing or flushing the eye with a suitable non-irritating solution.
Duration of treatment
Clinical experience suggests that 90% of dogs affected with KCS will require life-long therapy. However, if therapy is maintained the prognosis is good providing that regular clinical assessment is carried out. Current experience suggests that, in the treatment of `pannus', the frequency of application of Optimmune may be suspended or reduced during certain periods of the year when levels of ultraviolet light, which exacerbates this condition, are reduced.
|Registration number||REG NL 8631|
|Active Ingredient||Ciclosporin A|
|Legal status of supply||UDA|
|Withdrawal period||0 days|
|Expiry date||Apr 30, 2022|
|Units per outer box||0|
|Ingredients||Ciclosporine A 0,2 %|